|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01681 CONSUN PHARMA
Nominal 
9.260 -0.240 (-2.526%) Profitability Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| ROAA (%) | 16.028% | 15.087% | 14.757% | 14.199% | 13.026% |
| ROAE (%) | 23.574% | 23.171% | 23.700% | 24.397% | 23.670% |
| Return on Capital Employed (%) | 20.312% | 19.550% | 19.281% | 19.638% | 19.049% |
Margin Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Gross Profit Margin (%) | 75.562% | 74.193% | 75.349% | 74.699% | 75.402% |
| EBITDA Margin (%) | 34.401% | 34.521% | 33.392% | 36.314% | 37.028% |
| Pre-tax Profit Margin (%) | 34.379% | 33.346% | 31.902% | 34.033% | 33.302% |
| Net Profit Margin (%) | 30.684% | 30.290% | 29.188% | 28.864% | 28.456% |
Liquidity Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Current Ratio (X) | 3.320 X | 2.862 X | 2.682 X | 2.251 X | 1.996 X |
| Quick Ratio (X) | 3.109 X | 2.616 X | 2.478 X | 2.072 X | 1.826 X |
Leverage Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Total Liabilities / Total Assets(%) | 24.945% | 28.854% | 29.707% | 33.281% | 36.295% |
| Total Debt / Total Assets (%) | 4.565% | 9.287% | 9.406% | 14.004% | 13.908% |
| Net Debt / Total Assets (%) | -45.113% | -40.609% | -40.675% | -36.338% | -35.209% |
| Total Debt / Shareholders' Funds (%) | 6.520% | 14.105% | 14.631% | 23.340% | 24.744% |
| Long Term Debt / Shareholders' Funds (%) | 0.181% | 0.107% | 0.189% | 0.327% | 0% |
| Net Debt / Shareholders' Funds (%) | -64.440% | -61.677% | -63.272% | -60.563% | -62.641% |
| Net Cash / (Debt) ($) | 2.641B | 2.237B | 1.990B | 1.585B | 1.391B |
| Net Cash / (Debt) per share ($) | 3.109 | 2.758 | 2.466 | 1.923 | 1.697 |
| Total Debt / Capital Employed (%) | 5.961% | 12.747% | 12.992% | 20.330% | 20.983% |
| Interest Coverage Ratio (X) | 41.988 X | 41.618 X | 69.270 X | 54.922 X | 28.276 X |
Efficiency Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Inventory Turnover (Day) | 165.293 Day | 175.601 Day | 164.266 Day | 165.949 Day | 185.420 Day |
| Receivables Turnover (Day) | 34.038 Day | 36.315 Day | 47.643 Day | 71.385 Day | 126.226 Day |
| Payables Turnover (Day) | 9.763 Day | 10.075 Day | 9.870 Day | 10.490 Day | 11.079 Day |
| Remarks: | Real time quote last updated: 30/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 910,458 |
| %Change | 16.051% |
| EPS / (LPS) | RMB 1.110 |
| NBV Per Share (¥) | RMB 4.824 |